(Pro)renin Receptor is Involved in Myocardial Damage in Alcoholic Cardiomyopathy

Jie Xiong1,2, Xinran Cao1,2, Shiyuan Qiao1,2

  • 1From the, Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

Abstract

Insights

The (pro)renin receptor (PRR) is involved in alcoholic cardiomyopathy (ACM) development. Silencing PRR reduced cardiac fibrosis, oxidative stress, and inflammation, suggesting PRR as a potential therapeutic target for ACM.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Pharmacology

Background:

  • The (pro)renin receptor (PRR) is implicated in cardiovascular diseases.
  • The role of PRR in alcoholic cardiomyopathy (ACM) remains largely unknown.
  • ACM is characterized by myocardial damage and cardiac dysfunction due to alcohol intake.

Purpose of the Study:

  • To investigate the role of PRR in the pathogenesis of ACM.
  • To explore the potential of PRR as a therapeutic target for ACM.

Main Methods:

  • PRR gene silencing was performed using short hairpin RNA (shRNA) delivered via adenovirus.
  • In vitro studies involved primary rat cardiac fibroblasts treated with alcohol and PRR-shRNA.
  • In vivo studies utilized Wistar rats fed an alcohol-containing diet and treated with PRR-shRNA.

Main Results:

  • Alcohol significantly upregulated PRR expression in cardiac fibroblasts in a time- and concentration-dependent manner.
  • PRR silencing prevented alcohol-induced increases in fibrotic factors and ERK1/2 phosphorylation.
  • PRR silencing attenuated cardiac fibrosis, oxidative stress, and inflammation in vivo.

Conclusions:

  • PRR-ERK1/2 signaling pathway is implicated in the development of ACM.
  • Targeting PRR may offer a novel therapeutic strategy for treating alcoholic cardiomyopathy.

Related Concept Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

This protocol outlines a method for inducing diabetic cardiomyopathy through a combination of high-fat diet feeding and streptozotocin injection. This approach aims to provide a reliable framework for scientific investigation into diabetic cardiomyopathy and to explore potential avenues for clinical treatment...
1.3K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

A modified 2 kidney 1 clip (2K1C) Goldblatt mouse model was developed using polyurethane tubing to initiate renal artery stenosis, inducing an increase in renin expression and kidney injury. Here, we describe a detailed procedure of preparing and placing the cuff onto the renal artery to generate a reproducible and consistent 2K1C mouse...
5.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
482
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
478
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Zebrafish Cardiomyopathy Model: Drug-Induced Cardiotoxicity04:47

Zebrafish Cardiomyopathy Model: Drug-Induced Cardiotoxicity

This video describes the technique of creating a zebrafish cardiomyopathy model with minimal variations among experimental groups and in the sample, we create zebrafish cardiomyopathy model using the drug...
2.4K